MYAM
AGN

Meiji Yasuda Asset Management’s Allergan Inc AGN Stock Holding History

Meiji Yasuda Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-18,026
Closed -$3.83M – 372
2014
Q4 		$3.83M Sell
18,026
-1,621
-8% -$322K 0.92% 26
2014
Q3 		$3.5M Sell
19,647
-5,649
-22% -$938K 0.82% 28
2014
Q2 		$4.28M Sell
25,296
-743
-3% -$116K 0.88% 29
2014
Q1 		$3.23M Sell
26,039
-2,053
-7% -$250K 0.7% 48
2013
Q4 		$3.12M Buy
28,092
+402
+1% +$38.4K 0.66% 55
2013
Q3 		$2.5M Sell
27,690
-5,405
-16% -$485K 0.57% 59
2013
Q2 		$2.8M Buy
+33,095
New +$3.43M 0.66% 48

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Meiji Yasuda Asset Management's AGN Position: Q1 2015 in Review

Meiji Yasuda Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 18,026 shares — an estimated $3.83M sold.

Meiji Yasuda Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $4.28M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Meiji Yasuda Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Meiji Yasuda Asset Management sold 18,026 Allergan Inc shares in Q1 2015, an estimated $3.83M.
  • Meiji Yasuda Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Meiji Yasuda Asset Management's Allergan Inc position peaked at $4.28M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Meiji Yasuda Asset Management's 13F filing for Q1 2015, filed 13 May 2015.